Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR0302 in adults with moderate-to-severe alopecia areata
CTR20200343Phase 2Completed
- Sponsor
- Reistone Biopharma
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ivarmacitinib in alopecia areata, sponsored by Reistone Biopharma. Started Jul 2020; status: completed.
02
Drugs
ivarmacitinib
03
Conditions
alopecia areata
Beyond the preview
Go deeper on CTR20200343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200343.